Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-05-21

FDA Approved: KETOCONAZOLE — Original Application (Xiromed, LLC)

View source ↗

Summary

FDA has approved Xiromed, LLC's original generic application for Ketoconazole Foam, a topical antifungal 2% product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketoconazole Foam (ketoconazole)

Snippet

ORIG AP for KETOCONAZOLE (KETOCONAZOLE FOAM)